title: [Neuroretinopathy in dialyzed patients].
abstract: Over the past 11 years, neuroretinopathy was seen in 26 hemodialyzed patients, in an average 5.3% of the patients receiving treatment. During the past 4 years, the rate of incidence had dropped to 1.6%. Neuroretinopathy is most likely to develop in the first two years of artificial kidney treatment. The mean survival time following an attack of neuroretinopathy in 16 decreased patients was 19.4 months. Three patients underwent successful kidney transplantation, 50% were normotensives. As part of the subsequent search for other pathogenetic factors, a high incidence of pathological values of nitrogenous substances was found (urea in 77%, creatinine in 76%, uric acid in 42%). 85% suffered from electric retinal function impairment.
authors.forename: J
authors.initials: J
authors.lastname: Svĕrák
authors.forename: D
authors.initials: D
authors.lastname: Hejcmanová
authors.forename: J
authors.initials: J
authors.lastname: Peregrin
authors.forename: J
authors.initials: J
authors.lastname: Erben
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*; D012164:Retinal Diseases / Q000209:etiology*; D013997:Time Factors
vernacular_title: Neuroretinopatie u dialyzovaných nemocných.